How Long Can Repatha Be Unrefrigerated? The 9-Hour Stability Threshold
After 9 hours at hot room temperature, Repatha (evolocumab) loses about 10% of its PCSK9-inhibiting activity, and after 18 hours that loss climbs to 15%.
That matters because the drug's job is to drop LDL cholesterol by roughly 60%, which translates into about a 15% reduction in the combined risk of cardiovascular death, heart attack, stroke, hospitalization for unstable angina, and coronary revascularization in people with established cardiovascular disease. A medication doing that much heavy lifting shouldn't be quietly losing potency on a kitchen counter.
So how long can a Repatha pen actually sit out of the fridge before you should worry? The honest answer depends on three variables: ambient temperature, time, and whether you put a cold pack near it.
What the Manufacturer Says
The Repatha label calls for storage at 2–8°C (refrigerator) and explicitly warns against temperatures above 25°C. The label also allows brief excursions to room temperature when needed, but the question of "how brief" is exactly what stability research has tried to answer.
A 2021 experimental study tested both evolocumab and alirocumab in three real-world handling scenarios: bare room temperature, a small cooler with a cold pack, and a freeze-thaw cycle. The conditions were chosen to mirror what happens during travel, transport in tropical climates, and accidental freezer mishaps.
The 9-Hour Hot-Room Threshold
The room-temperature condition averaged 30.4°C across the test period, simulating an unair-conditioned summer day or a tropical climate. Results for evolocumab specifically broke down by condition:
| Condition (up to 18 hours) | Activity change vs. baseline | Practical reading | Citation |
|---|---|---|---|
| Hot room temperature, ~30°C | −9.7% at 9 hours, −15.1% at 18 hours | Measurable potency loss | |
| Cooler with cold pack (25→30°C) | No significant change | Safe up to 18 hours | |
| Freeze (−20°C) then thaw | Small, statistically non-significant change | Limited acute loss |
The drop after 9 hours was statistically significant for evolocumab (p = 0.04) and for alirocumab at the same exposure (p = 0.005). This matches the manufacturer's caution against temperatures above 25°C and gives a concrete number for what "above 25°C" actually costs you.
For people in temperate climates with air-conditioned homes, the implication is more forgiving than the headline numbers suggest. The 30°C tropical condition is harsher than a typical 22°C kitchen, and the activity-loss curve at lower temperatures was not what the 2021 study tested. The danger zone is hot rooms, parked cars, and summer travel, not a normally air-conditioned indoor space.
A Cooler Beats a Counter
The single most useful finding from the 2021 study: putting a pen in an insulated cooler with a frozen cold pack effectively neutralized the time problem. Internal temperatures crept from 25°C up toward 30°C over 18 hours, but evolocumab activity stayed flat. There was no significant decline in PCSK9 inhibition.
This has practical consequences. If you're flying with Repatha, taking it on a road trip, or carrying it through a hot day, a basic insulated lunch cooler with a single cold pack does the job. You do not need a medical-grade transport container. You do need a cold pack.
What About Freezing It By Accident?
Refrigerator drawers occasionally drop below 0°C, and people sometimes panic when they discover a Repatha pen has frozen. The 2021 data is reassuring on a single freeze-thaw cycle: changes in evolocumab activity were −1.8% at 9 hours and +0.4% at 18 hours, neither statistically significant.
That doesn't mean the drug is approved for freezing, and the study only tested a single freeze-thaw cycle. Repeated cycles were not measured. A single accidental freeze likely won't ruin a pen, but check with your prescribing clinician before injecting a previously frozen dose.
Why Even Small Efficacy Losses Matter
A 10% drop in PCSK9 inhibition might sound like a rounding error. It isn't, when you scale it across the kind of risk reduction this drug provides. The FOURIER trial randomized 27,564 patients with atherosclerotic cardiovascular disease and an LDL of 70 mg/dL or higher, all on statins. Over 2.2 years, evolocumab cut LDL from a median 92 mg/dL down to 30 mg/dL, reduced the primary composite endpoint by 15%, and reduced the harder secondary endpoint of cardiovascular death, MI, or stroke by 20%.
A 2019 meta-analysis of 39 trials and 66,478 patients confirmed the pattern across the broader PCSK9 inhibitor class: myocardial infarction risk fell by 20% (RR 0.80), ischemic stroke by 22% (RR 0.78), and coronary revascularization by 17% (RR 0.83). A separate analysis of 35 trials with 45,539 patients reached the same conclusions on cardiovascular events.
The point: this is a drug that earns its place through sustained LDL suppression, dose after dose. Letting it lose potency by leaving it on a hot counter for half a day chips away at that benefit on every shot.
Practical Handling Guide
A few decision rules that follow from the data:
- Refrigerator is home base. Keep unopened Repatha pens between 2–8°C. The fridge door is fine, but avoid the back wall where freezing can happen.
- Hot exposure plus more than 9 hours warrants a call. If a pen sat in a hot environment (close to 30°C) for longer than about 9 hours, the 2021 data say activity has measurably dropped. Call your pharmacy or prescribing clinician before injecting.
- Cooler plus cold pack for travel. A regular insulated cooler with one cold pack preserves activity for at least 18 hours. Use it for flights, road trips, and outdoor errands in summer.
- One accidental freeze is probably fine. Test data showed minimal evolocumab activity loss after a single freeze-thaw, but check before injecting and avoid repeating it.
When in Doubt, Replace the Pen
If a Repatha pen has been at room temperature for an unknown period or has clearly been exposed to high heat, the conservative move is to replace it rather than inject. The downside of using a heat-damaged pen is reduced LDL lowering, which is the entire reason you're taking the drug. The downside of replacing it is the cost of one pen.
If you're considering Repatha and want help getting started, Instalab's Repatha program pairs you with a licensed physician who handles the prescription, ongoing lab monitoring, and dose adjustments over time.

Prescribed by a licensed physician. Sent to your pharmacy.
References
4 studies- The Effect of Temperature on the Stability of PCSK-9 Monoclonal Antibody: An Experimental Study.
- Evolocumab and Clinical Outcomes in Patients With Cardiovascular Disease.
- Efficacy and Safety of Alirocumab and Evolocumab: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
- Effect of PCSK9 Inhibitors on Clinical Outcomes in Patients With Hypercholesterolemia: A Meta-analysis of 35 Randomized Controlled Trials.

